Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Hypertension
Interventions: celecoxib (Celebrex), Placebo; Drug · Other
Lead sponsor: University of Delaware; Other
Eligibility: 22 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Heart Failure, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: Francois Haddad; Other
Eligibility: 21 Years and older
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Aortic Stenosis
Interventions: Tadalafil, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Overweight and Obesity, Diabetes, Hypertension, Dyslipidemias, Cardiovascular Diseases
Interventions: PAI; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Prehypertension
Interventions: Grape Seed Extract, Placebo; Dietary Supplement
Lead sponsor: California Baptist University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Riverside, California

Conditions: Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: RTI International; Other
Eligibility: 18 Years and older · Female only
Enrollment: 4,048 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 14
States / cities: Orange, California • Newark, Delaware • Chicago, Illinois + 9 more

Conditions: Hypertension, Mineralocorticoid Excess
Interventions: Eplerenone, Amlodipine; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 17 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: clevidipine, nitroglycerin; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 629 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 28
States / cities: Birmingham, Alabama • Montgomery, Alabama • Tucson, Arizona + 19 more

Conditions: Hypertension, Hyperlipidemia, Diabetes
Interventions: Mobile Personal Health Record App.; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 311 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Conyers, Georgia

Conditions: Hypertension, FXTAS
Interventions: HRV and respiratory coherence biofeedback; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 50 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Primary Open Angle Glaucoma
Interventions: Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device, Cataract surgery; Device · Procedure
Lead sponsor: Nova Eye, Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Sugar Land, Texas

Conditions: Pulmonary Hypertension Associated With Interstitial Lung Disease
Interventions: Placebo, Seralutinib, Generic Dry Powder Inhaler; Drug · Device
Lead sponsor: GB002, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Fresno, California • Albuquerque, New Mexico • Richmond, Virginia

Conditions: Hemianopia, Hemianopsia, Peripheral Visual Field Defect, Blindness, Retinitis Pigmentosa, Glaucoma
Interventions: Collision warning device; Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Use of telephone-based Interactive Voice Recognition system; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 3
States / cities: Denver, Colorado • Metro Denver Area, Colorado

Conditions: Pulmonary Arterial Hypertension
Interventions: Sotatercept, SOC; Biological · Other
Lead sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: Tucson, Arizona • Boston, Massachusetts • Rochester, Minnesota + 1 more

Conditions: Obesity, Pre-hypertension, Hypertension
Interventions: Whole Body Vibration Training, Hypocaloric diet, Whole body vibration training & diet; Other
Lead sponsor: Florida State University; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Hypertension
Interventions: CIN-107; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 36
States / cities: Saraland, Alabama • Huntington Park, California • Lincoln, California + 32 more

Conditions: Chronic Fatigue Syndrome
Interventions: Placebo, Sodium Oxybate; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 21 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic, Cardiovascular Disease, Hyperinsulinemia
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 7 Years to 70 Years
Enrollment: 1,150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Arterial Hypertension
Interventions: UT-15C SR, treprostinil diethanolamine; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Caridovascular Disease, Congenital Heart Disease, Pulmonary Hypertension
Interventions: Cardiac Real-time MRI RHC (Right Heart Catheterization); Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 2 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension
Interventions: Smartphone-linked HBPM and associated app, Standard HBPM; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: San Francisco, California • Gainesville, Florida • New Orleans, Louisiana + 1 more

Conditions: Obesity, Metabolic Syndrome
Interventions: fructose restriction diet; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 8 Years to 18 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes Mellitus, Hypertension
Interventions: In Home Health Messaging Device; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)

Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study

Personal Activity Intelligence (PAI) Pilot

Effect of 7 Days of Grape Seed Extract Supplementation on Cold Pressor Test and Muscle Metaboreflex in Individuals With Elevated and Stage 1 Hypertension

Continuation of the nuMoM2b Heart Health Study

MR Antagonist and LSD1

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)

A Mobile Personal Health Record for Behavioral Health Homes

Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Collision Warning Device for Blind and Visually Impaired

Improving Blood Pressure in Colorado

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

Real-time MRI Right Heart Catheterization Using Passive Catheters

The PCORnet Blood Pressure Home Monitoring Study

Metabolic Impact of Fructose Restriction in Obese Children

Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes